{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:28:49Z","timestamp":1773278929299,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,4,3]],"date-time":"2003-04-03T00:00:00Z","timestamp":1049328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1007\/s00520-003-0440-1","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T03:47:54Z","timestamp":1576122474000},"page":"326-331","source":"Crossref","is-referenced-by-count":30,"title":["Opioid plasma concentration during switching from morphine to methadone: preliminary data"],"prefix":"10.1007","volume":"11","author":[{"given":"S.","family":"Mercadante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Villari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ferrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Casuccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Fulfaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Gebbia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,4,3]]},"reference":[{"key":"0440_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0885-3924(98)00151-1","volume":"17","author":"Bianchi","year":"1999","unstructured":"Bianchi M, Clavenna A, Groff L, et al (1999) Diclofenac does not modify methadone bioavailability in cancer patients. J Pain Symptom Manage 17:227\u2013229","journal-title":"J Pain Symptom Manage"},{"key":"0440_CR2","first-page":"93","volume":"11","author":"Breda","year":"1991","unstructured":"Breda M, Bianchi M, Ripamonti C, et al (1991) Plasma morphine and morphine-6-glucuronide patterns in cancer patients after oral, subcutaneous, sublabial and rectal short-term administration. Int J Clin Pharmacol Res 11:93\u201397","journal-title":"Int J Clin Pharmacol Res"},{"key":"0440_CR3","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO;2-T","volume":"78","author":"Bruera","year":"1996","unstructured":"Bruera E, Pereira J, Watanabe S, et al (1996) Opioid rotation in patients with cancer pain: a retrospective comparison of dose ratios between methadone, hydromorphone and morphine. Cancer 78:852\u2013857","journal-title":"Cancer"},{"key":"0440_CR4","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/1097-0142(19951001)76:7<1283::AID-CNCR2820760728>3.0.CO;2-0","volume":"76","author":"Cherny","year":"1995","unstructured":"Cherny NJ, Chang V, Frager G, et al (1995) Opioid pharmacotherapy in the management of cancer pain: A survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer 76:1283\u20131293","journal-title":"Cancer"},{"key":"0440_CR5","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1200\/JCO.2001.19.9.2542","volume":"19","author":"Cherny","year":"2001","unstructured":"Cherny N, Ripamonti C, Davis C, et al (2001) Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19:2542\u20132554","journal-title":"J Clin Oncol"},{"key":"0440_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdd.2510140102","volume":"14","author":"Ekblom","year":"1993","unstructured":"Ekblom M, Gardmark M, Hammarlund-Udenaes M: (1993) Pharmacokinetics and pharmacodynamics of morphine-3-glucuronide in rats and its influence on the antinociceptive effect of morphine. Biopharm Drug Dispos 14:1\u201311","journal-title":"Biopharm Drug Dispos"},{"key":"0440_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0304-3959(97)00142-5","volume":"74","author":"Faura","year":"1998","unstructured":"Faura CC, Collins SL, Moore RA, et al (1998) Systematic review of factors affecting the ratios of morphine and its major metabolites. Pain 74:43\u201353","journal-title":"Pain"},{"key":"0440_CR8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0304-3959(92)90065-J","volume":"48","author":"Gong","year":"1992","unstructured":"Gong Q-L, Hedner J, Bjorkman R, et al (1992) Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain 48:249\u2013255","journal-title":"Pain"},{"key":"0440_CR9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0885-3924(91)90961-3","volume":"6","author":"Hagen","year":"1991","unstructured":"Hagen NA, Foley KM, Cerbone DJ, et al (1991). Chronic nausea and morphine-6-glucuronide. J Pain Symptom Manage 6:125\u2013128","journal-title":"J Pain Symptom Manage"},{"key":"0440_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0885-3924(95)00021-P","volume":"10","author":"Hunt","year":"1995","unstructured":"Hunt G, Bruera E (1995) Respiratory depression in a patient receiving oral methadone for cancer pain. J Pain Symptom Manage 10:401\u2013404","journal-title":"J Pain Symptom Manage"},{"key":"0440_CR11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1600-0773.1989.tb01190.x","volume":"65","author":"Ivarsson","year":"1989","unstructured":"Ivarsson M, Neil A (1989): Differences in efficacies between morphine and methadone demonstrated in the guinea pig ileum: a possible explanation for previous observations on incomplete opioid cross-tolerance. Pharmacol Toxicol 65:368\u2013371","journal-title":"Pharmacol Toxicol"},{"key":"0440_CR12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s002280050003","volume":"55","author":"Klepstad","year":"2000","unstructured":"Klepstad P, Kaasa S, Borchgrevink PC (2000) Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine. Eur J Clin Pharmacol 55:713\u2013719","journal-title":"Eur J Clin Pharmacol"},{"key":"0440_CR13","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1167::AID-CNCR23>3.0.CO;2-3","volume":"82","author":"Lawlor","year":"1998","unstructured":"Lawlor PG, Turner KS, Hanson J, et al (1998) Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study. Cancer 82:1167\u20131173","journal-title":"Cancer"},{"key":"0440_CR14","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1200\/JCO.1999.17.10.3307","volume":"17","author":"Mercadante","year":"1999","unstructured":"Mercadante S, Casuccio A, Calderone L (1999) Rapid switching from morphine to methadone in cancer patients with poor response to morphine. J Clin Oncol 17:3307\u20133312","journal-title":"J Clin Oncol"},{"key":"0440_CR15","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G","volume":"86","author":"Mercadante","year":"1999","unstructured":"Mercadante S (1999) Opioid rotation for cancer pain: rationale and clinical aspects. Cancer 86:1856\u20131866","journal-title":"Cancer"},{"key":"0440_CR16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1090-3801(97)90064-1","volume":"1","author":"Mercadante","year":"1997","unstructured":"Mercadante S (1997) Methadone in cancer pain. Eur J Pain 1:77\u201385","journal-title":"Eur J Pain"},{"key":"0440_CR17","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1200\/JCO.1998.16.11.3656","volume":"16","author":"Mercadante","year":"1998","unstructured":"Mercadante S, Casuccio A, Agnello A, et al (1998) Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home. J Clin Oncol 16:3656\u20133661","journal-title":"J Clin Oncol"},{"key":"0440_CR18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1191\/026921699678158579","volume":"13","author":"Mercadante","year":"1999","unstructured":"Mercadante S (1999) The role of morphine glucuronides in cancer pain. Palliat Med 13:95\u2013104","journal-title":"Palliat Med"},{"key":"0440_CR19","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1200\/JCO.2001.19.11.2898","volume":"19","author":"Mercadante","year":"2001","unstructured":"Mercadante S, Casuccio A, Groff L, et al (2001) Switching from morphine to methadone to improbe analgesia and tolerability in cancer patients. A prospective study. J Clin Oncol 19:2898\u20132904","journal-title":"J Clin Oncol"},{"key":"0440_CR20","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0140-6736(92)93067-W","volume":"340","author":"Morley","year":"1992","unstructured":"Morley JS, Miles JB, Wells JC, et al (1992) Paradoxical pain. Lancet 340:1045","journal-title":"Lancet"},{"key":"0440_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0304-3959(96)03286-1","volume":"70","author":"Ripamonti","year":"1997","unstructured":"Ripamonti C, Zecca E, Bruera E (1997) An update on the clinical use of methadone for cancer pain. Pain 70:109\u2013115","journal-title":"Pain"},{"key":"0440_CR22","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1200\/JCO.1998.16.10.3216","volume":"16","author":"Ripamonti","year":"1998","unstructured":"Ripamonti C, Groff L, Brunelli C, et al (1998) Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol 16:3216\u20133221","journal-title":"J Clin Oncol"},{"key":"0440_CR23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/bja\/62.1.28","volume":"62","author":"Sear","year":"1989","unstructured":"Sear JW, Hand CW, Moore RA, et al (1989) Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites. Br J Anaesth 62:28\u201332","journal-title":"Br J Anaesth"},{"key":"0440_CR24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0024-3205(90)90619-3","volume":"47","author":"Smith","year":"1990","unstructured":"Smith MT, Watt JA, Cramond T (1990) Morphine-3-glucuronide: A potent antagonist of morphine analgesia. Life Sci 47:579\u2013585","journal-title":"Life Sci"},{"key":"0440_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0304-3959(96)03112-0","volume":"67","author":"Vigan\u00c3\u00b2","year":"1996","unstructured":"Vigan\u00f2 A, Fan D, Bruera E (1996) Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators. Pain 67:115\u2013119","journal-title":"Pain"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-003-0440-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-003-0440-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-003-0440-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T03:47:58Z","timestamp":1576122478000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-003-0440-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,3]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["0440"],"URL":"https:\/\/doi.org\/10.1007\/s00520-003-0440-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4,3]]}}}